MY167918A - Composition for use in the sublingual delivery of medicaments to humans - Google Patents
Composition for use in the sublingual delivery of medicaments to humansInfo
- Publication number
- MY167918A MY167918A MYPI2011005079A MYPI2011005079A MY167918A MY 167918 A MY167918 A MY 167918A MY PI2011005079 A MYPI2011005079 A MY PI2011005079A MY PI2011005079 A MYPI2011005079 A MY PI2011005079A MY 167918 A MY167918 A MY 167918A
- Authority
- MY
- Malaysia
- Prior art keywords
- medicaments
- humans
- composition
- sublingual delivery
- delivery
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 2
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical group [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 abstract 1
- 229960003711 glyceryl trinitrate Drugs 0.000 abstract 1
- 230000007935 neutral effect Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0906977A GB2469792A (en) | 2009-04-23 | 2009-04-23 | Oil-based pharmaceutical formulation for sublingual delivery |
| PCT/GB2009/050416 WO2010122276A1 (en) | 2009-04-23 | 2009-04-23 | Drug delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY167918A true MY167918A (en) | 2018-09-27 |
Family
ID=42236683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2011005079A MY167918A (en) | 2009-04-23 | 2010-04-23 | Composition for use in the sublingual delivery of medicaments to humans |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20120058158A1 (OSRAM) |
| EP (1) | EP2421503A1 (OSRAM) |
| JP (1) | JP2012524771A (OSRAM) |
| CN (1) | CN102458358A (OSRAM) |
| AU (1) | AU2010240653A1 (OSRAM) |
| BR (1) | BRPI1013539A2 (OSRAM) |
| CA (1) | CA2756879A1 (OSRAM) |
| IL (1) | IL215454A (OSRAM) |
| MX (1) | MX2011010835A (OSRAM) |
| MY (1) | MY167918A (OSRAM) |
| NZ (1) | NZ595467A (OSRAM) |
| RU (1) | RU2011139638A (OSRAM) |
| SG (1) | SG175160A1 (OSRAM) |
| WO (1) | WO2010122355A1 (OSRAM) |
| ZA (1) | ZA201107089B (OSRAM) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8852638B2 (en) | 2005-09-30 | 2014-10-07 | Durect Corporation | Sustained release small molecule drug formulation |
| US10512644B2 (en) | 2007-03-12 | 2019-12-24 | Inheris Pharmaceuticals, Inc. | Oligomer-opioid agonist conjugates |
| US8173666B2 (en) | 2007-03-12 | 2012-05-08 | Nektar Therapeutics | Oligomer-opioid agonist conjugates |
| WO2008153611A2 (en) | 2007-05-25 | 2008-12-18 | Qlt Usa, Inc. | Sustained delivery formulations of risperidone compounds |
| GB0720967D0 (en) * | 2007-10-25 | 2007-12-05 | Protophama Ltd | Anti-material pharmaceutical composition |
| GB2481017B (en) | 2010-06-08 | 2015-01-07 | Rb Pharmaceuticals Ltd | Microparticle buprenorphine suspension |
| US9272044B2 (en) | 2010-06-08 | 2016-03-01 | Indivior Uk Limited | Injectable flowable composition buprenorphine |
| US20130254139A1 (en) * | 2012-03-21 | 2013-09-26 | Xiaoguang Lei | Systems and methods for building a universal intelligent assistant with learning capabilities |
| GB201404139D0 (en) | 2014-03-10 | 2014-04-23 | Rb Pharmaceuticals Ltd | Sustained release buprenorphine solution formulations |
| US10376586B2 (en) | 2016-02-16 | 2019-08-13 | Entourage Bioscience, LLC | Method and compositions for solubilizing non-polar constituents |
| JP7653218B2 (ja) * | 2016-05-05 | 2025-03-28 | アクエスティブ セラピューティクス インコーポレイテッド | 送達増強エピネフリン組成物 |
| US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
| US12433850B2 (en) | 2016-05-05 | 2025-10-07 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine and prodrug compositions |
| US12427121B2 (en) | 2016-05-05 | 2025-09-30 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
| EP3558279A4 (en) * | 2016-12-26 | 2020-12-02 | Cellix Bio Private Limited | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CHRONIC PAIN |
| JP2020535162A (ja) * | 2017-09-27 | 2020-12-03 | アクエスティブ セラピューティクス インコーポレイテッド | 増強された送達のエピネフリン及びプロドラッグ組成物 |
| EP3902523A1 (en) | 2018-12-29 | 2021-11-03 | 3M Innovative Properties Company | Oral articles and methods of use |
| AU2021248263B2 (en) * | 2020-03-31 | 2024-09-19 | Remicine IP B.V. | Treatment of hyperinflammatory syndrome |
| WO2023076281A1 (en) | 2021-10-25 | 2023-05-04 | Aquestive Therapeutics, Inc. | Oral and nasal compositions and methods of treatment |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT84439B (pt) * | 1986-03-10 | 1989-10-04 | Burghart Kurt | Processo de preparacao de composicoes farmaceuticas a base de nifedipina |
| US5955098A (en) * | 1996-04-12 | 1999-09-21 | Flemington Pharmaceutical Corp. | Buccal non polar spray or capsule |
| US20050281752A1 (en) * | 1997-10-01 | 2005-12-22 | Dugger Harry A Iii | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
| EP1361864B9 (en) * | 2001-02-14 | 2014-07-09 | GW Pharma Limited | Liquid spray formulations for buccal delivery of cannabinoids |
| PT1976521E (pt) * | 2006-01-25 | 2015-06-09 | Insys Therapeutics Inc | Aerossol sublingual de fentanilo |
| WO2009020666A1 (en) * | 2007-08-06 | 2009-02-12 | Insys Therapeutics Inc. | Oral cannabinoid liquid formulations and methods of treatment |
| GB0720967D0 (en) * | 2007-10-25 | 2007-12-05 | Protophama Ltd | Anti-material pharmaceutical composition |
| NZ595469A (en) * | 2009-04-23 | 2013-10-25 | Londonpharma Ltd | Sublingual spray formulation comprising dihydroartemesinin |
-
2010
- 2010-04-23 MY MYPI2011005079A patent/MY167918A/en unknown
- 2010-04-23 AU AU2010240653A patent/AU2010240653A1/en not_active Abandoned
- 2010-04-23 RU RU2011139638/15A patent/RU2011139638A/ru unknown
- 2010-04-23 JP JP2012506583A patent/JP2012524771A/ja active Pending
- 2010-04-23 MX MX2011010835A patent/MX2011010835A/es active IP Right Grant
- 2010-04-23 CN CN2010800179717A patent/CN102458358A/zh active Pending
- 2010-04-23 SG SG2011073939A patent/SG175160A1/en unknown
- 2010-04-23 NZ NZ595467A patent/NZ595467A/xx not_active IP Right Cessation
- 2010-04-23 BR BRPI1013539A patent/BRPI1013539A2/pt not_active Application Discontinuation
- 2010-04-23 WO PCT/GB2010/050671 patent/WO2010122355A1/en not_active Ceased
- 2010-04-23 CA CA2756879A patent/CA2756879A1/en not_active Abandoned
- 2010-04-23 US US13/265,825 patent/US20120058158A1/en not_active Abandoned
- 2010-04-23 EP EP10715336A patent/EP2421503A1/en not_active Withdrawn
-
2011
- 2011-09-28 ZA ZA2011/07089A patent/ZA201107089B/en unknown
- 2011-10-02 IL IL215454A patent/IL215454A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP2421503A1 (en) | 2012-02-29 |
| SG175160A1 (en) | 2011-11-28 |
| JP2012524771A (ja) | 2012-10-18 |
| CN102458358A (zh) | 2012-05-16 |
| ZA201107089B (en) | 2012-12-27 |
| NZ595467A (en) | 2013-08-30 |
| WO2010122355A1 (en) | 2010-10-28 |
| AU2010240653A1 (en) | 2011-10-20 |
| IL215454A0 (en) | 2011-12-29 |
| IL215454A (en) | 2014-11-30 |
| BRPI1013539A2 (pt) | 2016-04-12 |
| CA2756879A1 (en) | 2010-10-28 |
| RU2011139638A (ru) | 2013-05-27 |
| US20120058158A1 (en) | 2012-03-08 |
| MX2011010835A (es) | 2012-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY167918A (en) | Composition for use in the sublingual delivery of medicaments to humans | |
| TN2011000471A1 (en) | Pharmaceutical composition presenting anti-inflammatory properties | |
| MY160456A (en) | Benzodiazepine bromodomain inhibitor | |
| IN2012DN02805A (OSRAM) | ||
| TN2012000059A1 (en) | Compositions comprising tramadol and celecoxib in the treatment of pain | |
| TN2015000278A1 (en) | Autotaxin inhibitors | |
| MX2010014041A (es) | Una forma cristalina de posaconazol. | |
| EA201290982A1 (ru) | Фармацевтические композиции, препятствующие злоупотреблению | |
| PH12015501096A1 (en) | Composition for immediate and extended release | |
| MX2013003635A (es) | Compuestos de n-heteroarilo. | |
| PH12015501982A1 (en) | Pharmaceutical compositions comprising everolimus | |
| TN2012000488A1 (en) | Pharmaceutical compositions comprising hydromorphone and naloxone | |
| WO2010092088A3 (de) | Verwendung von hydrophobin als spreitmittel | |
| TN2009000510A1 (en) | Extended release formulation of nevirapine | |
| GB201014391D0 (en) | Drug composition and its use in therapy | |
| EA201171414A1 (ru) | Ингибиторы белков семейства iap | |
| MX356373B (es) | Composiciones que comprenden un agente antibacterial y tazobactam. | |
| UA105944C2 (uk) | Комбінація теоброміну з деконгестантом і її застосування для лікування кашлю | |
| WO2007114946A3 (en) | Acid-sensitive linkers for drug delivery | |
| MX365285B (es) | Complejo lubricante para la boca. | |
| UA105675C2 (uk) | Бензодіазепіновий інгібітор бромодомену | |
| WO2011131925A3 (en) | Osmium (ii) arene azo anti-cancer complexes | |
| TN2011000352A1 (en) | New combination of active ingredients containing a non steroidal anti inflammatory drug and a colchicoside derivative | |
| TNSN08411A1 (en) | Derivatives of 2-alkoxy-3,4,5-trihydroxy-alkyl amides,preparation and use thereof,and compositions containing the same | |
| TNSN08442A1 (en) | 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzothiazepines, the preparation and use thereof, and compositions containing the same |